Financials

News Ideas Technicals

4192 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to SYNCORE BIOTECHNOL operating, investing, and financing activities

4192 free cash flow for Q1 24 is -20.33 M TWD. For 2023, 4192 free cash flow was -82.39 M TWD and operating cash flow was -81.98 M TWD.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: TWD

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—